Stephen P Raffanti

Summary

Publications

  1. ncbi request reprint Effect of persistent moderate viremia on disease progression during HIV therapy
    Stephen P Raffanti
    Comprehensive Care Center, Nashville, TN 37203, USA
    J Acquir Immune Defic Syndr 37:1147-54. 2004
  2. ncbi request reprint Time's up
    Stephen Raffanti
    Vanderbilt University, Nashville, TN 37203, USA
    Ann Intern Med 145:73-4. 2006
  3. pmc Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators
    Bryan E Shepherd
    Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232 2158, USA
    J Clin Epidemiol 62:729-37. 2009
  4. doi request reprint Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care
    Diana C Lemly
    School of Medicine, Department of Biostatistics, Vanderbilt University, Nashville, TN 37203, USA
    J Infect Dis 199:991-8. 2009
  5. ncbi request reprint Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy
    Jennifer H Tai
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    J Infect Dis 196:1044-52. 2007
  6. pmc Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
    April C Pettit
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232 2582, USA
    J Acquir Immune Defic Syndr 57:305-10. 2011
  7. ncbi request reprint Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy
    Todd Hulgan
    Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN 37203, USA
    J Infect Dis 195:425-31. 2007
  8. pmc Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures
    Peter F Rebeiro
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 2582, USA
    Clin Infect Dis 47:1354-7. 2008
  9. ncbi request reprint Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors
    Shaheena Asad
    Department of Internal Medicine, Divisions of Hematology Oncology, University School of Medicine, Nashville, TN, USA
    J Natl Med Assoc 100:1417-24. 2008
  10. ncbi request reprint Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system
    James E Bailey
    Division of General Internal Medicine, Department of Medicine, University of Tennessee Health Science Center, 66 N Pauline, Room 622, Memphis, TN 38105, USA
    Am J Manag Care 9:595-602. 2003

Collaborators

  • Bryan E Shepherd
  • Wayne Ray
  • Amy C Justice
  • Yi Wei Tang
  • T R Sterling
  • James E Bailey
  • TODD M HULGAN
  • Peter F Rebeiro
  • Asghar Kheshti
  • April C Pettit
  • Robert B Blackwell
  • Samuel E Stinnette
  • Diana C Lemly
  • Dawn E Maddux
  • Shaheena Asad
  • Jennifer H Tai
  • Bryan E Youree
  • Cathy A Jenkins
  • Peter Rebeiro
  • Samuel Stinnette
  • Sally Bebawy
  • RICHARD T D'AQUILA
  • Husamettin Erdem
  • Peter F Reibero
  • Jim Daugherty
  • Ashgar Kheshti
  • Sally S Bebawy
  • Beverly R Byram
  • Gema Barkanic
  • Justine D Carter
  • Mercy A Udoji
  • Cornelia R Graves
  • Daniel W Byrne
  • Jason D Morrow
  • Wendy A Mangialardi

Detail Information

Publications12

  1. ncbi request reprint Effect of persistent moderate viremia on disease progression during HIV therapy
    Stephen P Raffanti
    Comprehensive Care Center, Nashville, TN 37203, USA
    J Acquir Immune Defic Syndr 37:1147-54. 2004
    ..We evaluated whether risk of clinical progression varies by level of viral suppression achieved...
  2. ncbi request reprint Time's up
    Stephen Raffanti
    Vanderbilt University, Nashville, TN 37203, USA
    Ann Intern Med 145:73-4. 2006
  3. pmc Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators
    Bryan E Shepherd
    Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232 2158, USA
    J Clin Epidemiol 62:729-37. 2009
    ..To evaluate a model for predicting time to AIDS or death among HIV-infected persons initiating highly active antiretroviral therapy (HAART)...
  4. doi request reprint Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care
    Diana C Lemly
    School of Medicine, Department of Biostatistics, Vanderbilt University, Nashville, TN 37203, USA
    J Infect Dis 199:991-8. 2009
    ..There are conflicting data regarding race, sex, and mortality among persons infected with human immunodeficiency virus (HIV). We studied all-cause mortality among persons in care during the highly-active antiretroviral therapy (HAART) era...
  5. ncbi request reprint Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy
    Jennifer H Tai
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    J Infect Dis 196:1044-52. 2007
    ..Before the availability of highly active antiretroviral therapy (HAART), there was no clear effect of pregnancy on human immunodeficiency virus (HIV) disease progression. This has not been assessed during the HAART era...
  6. pmc Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
    April C Pettit
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232 2582, USA
    J Acquir Immune Defic Syndr 57:305-10. 2011
    ..To evaluate the short-term and long-term effects of highly active antiretroviral therapy (HAART) on tuberculosis (TB) risk compared with risk without HAART in a low TB incidence setting...
  7. ncbi request reprint Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy
    Todd Hulgan
    Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN 37203, USA
    J Infect Dis 195:425-31. 2007
    ....
  8. pmc Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures
    Peter F Rebeiro
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 2582, USA
    Clin Infect Dis 47:1354-7. 2008
    ..This artifact is attributable to shipping frozen plasma in primary plasma preparation tubes and is not caused by the HIV-1 RNA detection assay; it can be avoided by shipping plasma in a secondary tube...
  9. ncbi request reprint Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors
    Shaheena Asad
    Department of Internal Medicine, Divisions of Hematology Oncology, University School of Medicine, Nashville, TN, USA
    J Natl Med Assoc 100:1417-24. 2008
    ..We performed an observational cohort study to determine the influence of race, sex and other sociodemographic factors on early ART discontinuations among HIV-infected persons...
  10. ncbi request reprint Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system
    James E Bailey
    Division of General Internal Medicine, Department of Medicine, University of Tennessee Health Science Center, 66 N Pauline, Room 622, Memphis, TN 38105, USA
    Am J Manag Care 9:595-602. 2003
    ..Some experimental Medicaid managed care systems have expanded eligibility criteria for chronically ill persons, but these systems' impact on access to care remains unknown...
  11. doi request reprint Misdiagnosis of HIV infection: implications for universal testing
    Dawn E Maddux
    AIDS 22:546-7. 2008
  12. ncbi request reprint Fulminant Kaposi's sarcoma without mucocutaneous disease
    Bryan E Youree
    AIDS 17:788-90. 2003